LENZ Therapeutics (LENZ) Depreciation & Amortization (CF) (2020 - 2026)
LENZ Therapeutics (LENZ) reported Depreciation & Amortization (CF) of $111000.0 for Q1 2026, up 208.33% year-over-year from $36000.0 in Q1 2025, and up 3.74% quarter-over-quarter from $107000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $111000.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $111000.0, up 208.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $362000.0 (up 306.74% YoY), and the FY2025 annual result was $287000.0, up 394.83% from the prior year.
- Depreciation & Amortization (CF) advanced to $111000.0 in Q1 2026 per LENZ's latest filing, from $107000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $682000.0 in Q4 2022 and troughed at $3000.0 in Q1 2023.
- A 5-year average of $166058.8 and a median of $25000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) slumped 99.41% in 2023, then surged 1150.0% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $682000.0 in 2022, then tumbled by 99.41% to $4000.0 in 2023, then soared by 525.0% to $25000.0 in 2024, then surged by 328.0% to $107000.0 in 2025, then climbed by 3.74% to $111000.0 in 2026.
- Business Quant data shows LENZ's Depreciation & Amortization (CF) at $111000.0 in Q1 2026, $107000.0 in Q4 2025, and $125000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 429,663.65 |
| 10 | LENZ Therapeutics | 213.20 Mn | 213.20 Mn | 825,000.00 | 111,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111,000.00 |
| Mar 31, 2026 | 111,000.00 |
| Dec 31, 2025 | 107,000.00 |
| Dec 31, 2025 | 107,000.00 |
| Sep 30, 2025 | 125,000.00 |
| Sep 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |